{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:21:30Z","timestamp":1785453690382,"version":"3.56.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s10147-024-02668-z","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T20:09:09Z","timestamp":1733256549000},"page":"380-388","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prospective changes in financial toxicity and health-related quality of life in patients with gynecologic cancer"],"prefix":"10.1007","volume":"30","author":[{"given":"Kazunori","family":"Honda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3681-5757","authenticated-orcid":false,"given":"Yusuke","family":"Kajimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohshiro","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anri","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Shibutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Koyanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izumi","family":"Kohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuko","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midori","family":"Yabuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lida","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ataru","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"issue":"2","key":"2668_CR1","first-page":"80","volume":"27","author":"SY Zafar","year":"2013","unstructured":"Zafar SY, Abernethy AP (2013) Financial toxicity, Part I: a new name for a growing problem. Oncology (Williston Park) 27(2):80\u2013149","journal-title":"Oncology (Williston Park)"},{"issue":"20","key":"2668_CR2","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1002\/cncr.28814","volume":"120","author":"JA de Souza","year":"2014","unstructured":"de Souza JA et al (2014) The development of a financial toxicity patient-reported outcome in cancer: the COST measure. Cancer 120(20):3245\u20133253","journal-title":"Cancer"},{"issue":"3","key":"2668_CR3","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/cncr.30369","volume":"123","author":"JA de Souza","year":"2017","unstructured":"de Souza JA et al (2017) Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST). Cancer 123(3):476\u2013484","journal-title":"Cancer"},{"key":"2668_CR4","doi-asserted-by":"crossref","unstructured":"Ebi H, Bando H. Precision oncology and the universal health coverage system in Japan. JCO Precis Oncol. 2019; 3.","DOI":"10.1200\/PO.19.00291"},{"key":"2668_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JGO.19.11000","volume":"5","author":"K Honda","year":"2019","unstructured":"Honda K et al (2019) Prospective survey of financial toxicity measured by the comprehensive score for financial toxicity in Japanese patients with cancer. J Glob Oncol 5:1\u20138","journal-title":"J Glob Oncol"},{"key":"2668_CR6","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3332\/ecancer.2018.847","volume":"12","author":"K Honda","year":"2018","unstructured":"Honda K et al (2018) A prospective survey of comprehensive score for financial toxicity in Japanese cancer patients: report on a pilot study. Ecancermedicalscience 12:847","journal-title":"Ecancermedicalscience"},{"issue":"3","key":"2668_CR7","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s10147-023-02294-1","volume":"28","author":"Y Kajimoto","year":"2023","unstructured":"Kajimoto Y et al (2023) Association between financial toxicity and health-related quality of life of patients with gynecologic cancer. Int J Clin Oncol 28(3):454\u2013467","journal-title":"Int J Clin Oncol"},{"key":"2668_CR8","unstructured":"Kajimoto Y, et al. Validity of the COmprehensive Score for financial Toxicity (COST) in patients with gynecologic cancer. Int J Gynecol Cancer, 2022."},{"issue":"8","key":"2668_CR9","doi-asserted-by":"publisher","first-page":"e1094","DOI":"10.1200\/OP.20.00721","volume":"17","author":"C Friedes","year":"2021","unstructured":"Friedes C et al (2021) Longitudinal trends of financial toxicity in patients with lung cancer: a prospective cohort study. JCO Oncol Pract 17(8):e1094\u2013e1109","journal-title":"JCO Oncol Pract"},{"issue":"12","key":"2668_CR10","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1111\/iju.15039","volume":"29","author":"K Nezu","year":"2022","unstructured":"Nezu K et al (2022) Association of financial toxicity with quality of life in testicular cancer survivors. Int J Urol 29(12):1526\u20131534","journal-title":"Int J Urol"},{"issue":"4","key":"2668_CR11","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/ajco.13901","volume":"19","author":"H Jiang","year":"2023","unstructured":"Jiang H et al (2023) Association between financial toxicity and health-related quality of life in cancer survivors: a systematic review. Asia Pac J Clin Oncol 19(4):439\u2013457","journal-title":"Asia Pac J Clin Oncol"},{"issue":"4","key":"2668_CR12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.5897","volume":"6","author":"LV Ghazal","year":"2023","unstructured":"Ghazal LV et al (2023) Financial toxicity and its association with health-related quality of life among partners of colorectal cancer survivors. JAMA Netw Open 6(4):e235897","journal-title":"JAMA Netw Open"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-024-02668-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-024-02668-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-024-02668-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T11:56:47Z","timestamp":1738324607000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-024-02668-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["2668"],"URL":"https:\/\/doi.org\/10.1007\/s10147-024-02668-z","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"assertion":[{"value":"16 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Kazunori Honda received research funding from Pfizer Japan Inc. outside the submitted work. Yusuke Kajimoto is an employee of MSD K.K. Ataru Igarashi received research funding from Abbott, AbbVie GK, Becton, Dickinson and Company, Creative Ceuticals, Eli Lilly Japan K.K., Gilead Sciences, Intuitive Surgical, Milliman, Pfizer Japan Inc., Sanofi Pasteur, and Terumo and personal fees from Astellas Pharma Inc., Chugai Pharmaceutical Co., CSL Behring, FUJIFILM, Sanofi, and Takeda, outside the submitted work. The other authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}